IBA is a global leader in proton therapy solutions for the treatment of cancer.

 

Background

  • Growing success of the business did not yet have the international recognition it deserved
  • Proton therapy was a misunderstood modality that was seen as expensive with sceptical clinical relevance

1/2

of the world’s proton therapy centers installed by IBA

 

Our strategy

  • Enhance profile across global financial community and media
  • Alongside Senior Management at IBA, communicate proton therapy market potential
  • Specialised investor events, financial conferences and analyst relations to enhance understanding of the business and the market opportunity

 

Outcome

  • Enhanced profile and understanding, of the potential of the proton therapy market
  • Heightened international interest with all stakeholders and attracting new global investors